Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.

Håkan Wallén N, Li N, Eriksson-Berg M, Landgren BM, Schenck-Gustafsson K, Hjemdahl P.

Thromb Haemost. 2006 Dec;96(6):862-3. No abstract available.

PMID:
17139389
[PubMed - indexed for MEDLINE]
2.

Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.

Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM.

Menopause. 2008 Nov-Dec;15(6):1060-4. doi: 10.1097/gme.0b013e31816d8171.

PMID:
18521047
[PubMed - indexed for MEDLINE]
3.

Dose response effect of conjugated equine oestrogen on blood pressure in postmenopausal women with hypertension.

Harvey PJ, Molloy D, Upton J, Wing LM.

Blood Press. 2000;9(5):275-82.

PMID:
11193131
[PubMed - indexed for MEDLINE]
4.

Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.

Lamon-Fava S, Posfai B, Schaefer EJ.

Am J Cardiol. 2003 Jan 15;91(2):252-4. No abstract available.

PMID:
12521647
[PubMed - indexed for MEDLINE]
5.

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.

PMID:
18064330
[PubMed - indexed for MEDLINE]
6.

Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.

Yeboah J, Reboussin DM, Waters D, Kowalchuk G, Herrington DM.

Am Heart J. 2007 Mar;153(3):439-44.

PMID:
17307425
[PubMed - indexed for MEDLINE]
7.

The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.

Blum I, Vered Y, Lifshitz A, Harel D, Blum M, Nordenberg Y, Harsat A, Sulkes J, Gabbay U, Graff E.

Isr J Med Sci. 1996 Dec;32(12):1158-62.

PMID:
9007144
[PubMed - indexed for MEDLINE]
8.

The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women.

Bar J, Tepper R, Fuchs J, Pardo Y, Goldberger S, Ovadia J.

Obstet Gynecol. 1993 Feb;81(2):261-4.

PMID:
8380912
[PubMed - indexed for MEDLINE]
9.

Pulse pressure and coronary atherosclerosis progression in postmenopausal women.

Nair GV, Waters D, Rogers W, Kowalchuk GJ, Stuckey TD, Herrington DM.

Hypertension. 2005 Jan;45(1):53-7. Epub 2004 Nov 15.

PMID:
15545509
[PubMed - indexed for MEDLINE]
Free Article
10.

Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.

Cerquetani E, Vitale C, Mercuro G, Fini M, Zoncu S, Rosano GM.

Gynecol Endocrinol. 2004 Jun;18(6):291-8.

PMID:
15497491
[PubMed - indexed for MEDLINE]
11.

Effect of estrogen-progestin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women.

Bonduki CE, Lourenço DM, Motta EL, Soares Jr JM, Haidar MA, Baracat EC.

Clinics (Sao Paulo). 2007 Oct;62(5):553-60.

PMID:
17952314
[PubMed - indexed for MEDLINE]
Free Article
12.

The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women.

Tepper R, Bar J, Goldberger S, Fuchs J, Beyth Y, Ovadia J.

Maturitas. 1996 May;24(1-2):51-6.

PMID:
8794434
[PubMed - indexed for MEDLINE]
13.

Estrogen replacement suppresses function of thrombin stimulated platelets by inhibiting Ca(2+) influx and raising cyclic adenosine monophosphate.

Nakano Y, Oshima T, Ozono R, Ueda A, Oue Y, Matsuura H, Sanada M, Ohama K, Chayama K, Kambe M.

Cardiovasc Res. 2002 Feb 15;53(3):634-41.

PMID:
11861034
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of estrogen-only treatment in postmenopausal women.

Campagnoli C, Abbà C, Ambroggio S, Peris C.

JAMA. 2004 Aug 11;292(6):684; author reply 685-6. No abstract available.

PMID:
15304458
[PubMed - indexed for MEDLINE]
15.

Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.

Nas T, Sargon MF, Celik HH, Keskin PO, Gürsoy RH, Biberoglu K.

Saudi Med J. 2007 Dec;28(12):1917-9. No abstract available.

PMID:
18060233
[PubMed - indexed for MEDLINE]
16.

Comparison of effects of pravastatin and hormone therapy on soluble P-selectin and platelet P-selectin expression in postmenopausal hypercholesterolemic women.

Peverill RE, Smolich JJ, Malan E, Goldstat R, Davis SR.

Maturitas. 2006 Jan 20;53(2):158-65.

PMID:
16368469
[PubMed - indexed for MEDLINE]
17.

Sympathetic skin response in women receiving hormone replacement therapy.

Kutlar I, Yilmaz M, Balat O.

Int J Gynaecol Obstet. 2004 Feb;84(2):181-2. No abstract available.

PMID:
14871527
[PubMed - indexed for MEDLINE]
18.

Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.

Toth MJ, Sites CK, Matthews DE.

Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E639-46. Epub 2006 May 9.

PMID:
16684855
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease.

Greiner DZ, Personius BE, Andrews TC.

Am J Cardiol. 1999 Jan 15;83(2):247-9, A5.

PMID:
10073827
[PubMed - indexed for MEDLINE]
20.

Submaximal exercise coronary artery flow increases in postmenopausal women without coronary artery disease after estrogen and atorvastatin.

Puntawangkoon C, Morgan TM, Herrington DM, Hamilton CA, Hundley WG.

Menopause. 2010 Jan-Feb;17(1):114-20. doi: 10.1097/gme.0b013e3181b63c4d.

PMID:
19752761
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk